Statistics from Altmetric.com
REGULATION of veterinary medicines following the UK's exit from the European Union (EU) must incentivise product research and development, the National Office of Animal Health (NOAH) has said.
Setting out priority areas for ensuring a thriving animal health sector in the UK after Brexit, NOAH, which represents the UK animal medicines industry, says that measures must be in place to facilitate trade and innovation.
Commenting after a NOAH board meeting on November 1, Cat Sayer, chair of NOAH, said: ‘The UK must continue to be a vibrant and innovative animal health market, …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.